News

Annovis Bio's Participation in Key Neuroscience Conference

Annovis Bio's Participation in Key Neuroscience Conference

Annovis Bio to Participate in Renowned Neuroscience Event

MALVERN, Pa. — Annovis Bio Inc. (NYSE: ANVS), a prominent clinical-stage biopharmaceutical company focused on pioneering innovative therapies for neurodegenerative diseases, is thrilled to announce its participation in the upcoming AD/PD™ 2025 conference.

Highlights from the Conference

This prestigious event, set to take place in Vienna from April 1-5, will see Annovis showcasing vital research findings related to Alzheimer's disease (AD) and Parkinson's disease (PD), two conditions that greatly impact millions worldwide. During the conference, Annovis will present data from its latest clinical studies, which underscore the potential of its lead product, buntanetap, in effectively treating these conditions.

Presentations on Groundbreaking Research

The company has scheduled two significant presentations and a forum discussion at the conference:

First Presentation: Buntanetap Improves Early Parkinson's Patients' Cognition and Motor Functions in a Phase 3 Study
Date: April 1
Time: 2:45 – 3:00 PM CET
Presenter: Maria Maccecchini, Ph.D., Founder and CEO

Second Presentation: APOE4 and Buntanetap in Phase II/III Alzheimer’s Patients
Date: April 2
Time: 9:40 – 9:55 AM CET
Presenter: Cheng Fang, Ph.D., SVP, Research and Development

Additionally, Annovis will participate in a forum discussion titled Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies Linked to PD, LBD, and MSA on April 4 from 4:20 to 5:20 PM CET, featuring discussion led by Dr. Maccecchini.

Significance of the AD/PD™ Conference

The AD/PD™ conference is a crucial platform that brings together leading experts from around the world to discuss recent advancements in the fields of Alzheimer's and Parkinson's research. This year's conference will highlight the latest breakthroughs in drug development, early diagnosis techniques, and translational research, allowing researchers and clinicians to engage with pivotal ideas and collaborations that may shape the future of treatment in neurodegenerative diseases.

About Annovis Bio

Based in Malvern, Pennsylvania, Annovis is on a mission to tackle the challenges of neurodegeneration in diseases such as Alzheimer's and Parkinson's. The company is committed to innovating therapies that aim to enhance not just the clinical outcomes for patients but also their quality of life.

Staying Informed

Interested individuals can learn more by visiting Annovis's website, where updates and more information regarding their innovative approaches and ongoing trials can be found.

Contact Details for Inquiries

For further inquiries, reach out to:
Annovis Bio Inc.
101 Lindenwood Drive
Suite 225
Malvern, PA 19355
Website: www.annovisbio.com

Investor Communications

Investors and shareholders are encouraged to register for email alerts on press releases and industry updates, ensuring they remain informed on developments within the company and the field.

Frequently Asked Questions

What is Annovis Bio focused on?

Annovis Bio concentrates on developing innovative therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

When will Annovis present at the conference?

Annovis will hold its first presentation on April 1 and a second on April 2 at the AD/PD 2025 conference.

Who are the presenters from Annovis Bio?

Maria Maccecchini, Ph.D., and Cheng Fang, Ph.D., will be giving the key presentations during the conference.

Where is the conference being held?

The AD/PD 2025 conference is set to take place in Vienna.

How can I stay updated with Annovis Bio news?

Visit the company's website and register for email alerts to stay informed about ongoing research and company news.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

College Towns Spark Entrepreneurial Booms Across US

Updated Category News Views 0

Entrepreneurial Sparks Fly in Unlikely Places Turns out, it's not just the Silicon Valleys of the world creating startups—sometimes it's the coffee-driven college town where innovation quietly roots itself. GoDaddy's inaugural list of America's Most Entrepreneurial College Towns decimates the old idea that only big cities can be entrepreneurial havens. Instead, eight...

Continue Reading
BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy

Updated Category News Views 26

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

Continue Reading
Quaker Houghton Propels Forward with Q3 2026 Gains

Updated Category News Views 28

Quaker Houghton's Strategy Yields Positive Q3 2026 Results Imagine getting through another quarter against global economic headwinds and coming out profitable. That’s exactly what Quaker Houghton (NYSE:KWR) pulled off in Q3 2026. Their net sales jumped to a solid $544.5 million, marking a 10% increase from the same quarter last year. Not bad for a company that had its...

Continue Reading
Cboe's Third Quarter Packs a Punch with Strong Gains

Updated Category News Views 41

Making Waves in the Market There's no sugar-coating it—Cboe Global Markets has had a hell of a third quarter in 2026. With their diluted EPS climbing to a record $4.08, a 43% jump from last year, it's no surprise their stock ticker, CBOE, is catching some eyes. Adjusted diluted EPS also made a splash, soaring 36% to $3.63 compared to 2025 figures. Their strategic moves...

Continue Reading
OneMain Holdings' Q3 2026: Mixed Signals in Nonprime Sector

Updated Category News Views 10

Third Quarter Earnings: A Double-Edged Sword OneMain Holdings, Inc. (NYSE: OMF) rolled its Q3 2026 numbers out, and they look like a classic cocktail of high hopes and looming risks. On the surface, a diluted EPS of $1.60 might not sound like a knockout punch to the jaw, but let’s not forget they’ve taken a step back from last year’s $1.67. Their net income of $185...

Continue Reading
MediaGo Wins Big in France with Optimized Strategies

Updated Category News Views 47

MediaGo's Winning Edge in Advertising Shake the dust off your boots and get ready for a tale of triumph straight out of San Francisco. MediaGo, the top dog in global intelligent advertising platforms, just added a couple of shiny awards to its trophy case thanks to the prestigious Les Cas d'OR 2026 in France. And let me tell ya, these wins aren't just about some pretty...

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 29

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Senior Living Amenities: Beyond the Initial Tour Expectations

Updated Category News Views 0

Untangling the Frontloaded Focus on Senior Living When folks first wade into the sea of senior living options, they tend to hitch their wagons to the more obvious aspects like apartment size and healthcare services. But man, do we all sometimes get lost in the forest for the trees. What swerves the experience most in the senior community sphere are those amenities folks...

Continue Reading
SOTERIA Launches Cancer Hunt™ for Military Patients

Updated Category News Views 66

Breaking the Barriers for Our Military's Cancer Fight Diving into the world of precision medicine, SOTERIA Precision Medicine Foundation has sparked a revolution with Cancer Hunt™. It's staggering to think about the piles of bureaucracy and insurance red tape that often stand between cancer patients and life-saving care. Especially when those patients are veterans or...

Continue Reading
XREAL AURA: A New Era of Wired XR Glasses

Updated Category News Views 95

Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...

Continue Reading

Top 5 Most Recently Viewed Articles

Breakthrough in Major Depression Treatment with NeuLogiq® Insights

Updated Category News Views 125

NeuLogiq® Platform Proves Effective in Major Depressive Disorder Trials The groundbreaking NeuLogiq® Platform showcased by Delix Therapeutics at a recent clinical conference is paving the way for improved treatments for Major Depressive Disorder (MDD). This platform is confirmed to effectively detect pharmacodynamic signals, providing essential insights into patient...

Continue Reading
Understanding Ford Motor Company's Debt-to-Equity Ratio

Updated Category News Views 517

Ford Motor Company (NYSE: F) recently found itself under scrutiny for its debt-to-equity ratio, which some hailed as a badge of honor. Traders were abuzz with chatter about a figure sitting at 3.46, a number that screams risk and opportunity all at once. But hold on; this isn’t just a number game—context is everything. Decoding Ford’s Debt-to-Equity Ratio The...

Continue Reading
VistaGen Therapeutics Faces Market Struggles Despite Promising Trials

Updated Category News Views 212

VistaGen Therapeutics Stock Performance VistaGen Therapeutics Inc. (NASDAQ: VTGN) is facing considerable challenges in the stock market. Having recently reached a 52-week low of $2.51, the company is under significant pressure, reflecting a broader downturn in the biotech sector. Over the past year, VistaGen's stock has declined by 24.48%, showcasing the tough landscape...

Continue Reading
Oral Care Market Trends: Innovative Products for Growth in Health

Updated Category News Views 167

A Bright Future for the Oral Care Market The global oral care market is on an astonishing growth trajectory, currently valued at USD 40.56 billion, with predictions pointing towards a remarkable USD 77.87 billion by the end of the next decade. This remarkable increase signals a profound shift in how consumers view their oral health, driven by a variety of factors from...

Continue Reading
The Summit's Bold Debut Album Set to Ignite the Rock Scene

Updated Category News Views 209

The Summit's Bold Debut Album Set to Ignite the Rock Scene The Summit, a rock band known for their electrifying performances and captivating sound, is ready to release their highly anticipated debut album, Firebirds and Aviators. This exciting new record is expected to resonate with fans as they showcase their signature, guitar-driven sound. Album Details and Production...

Continue Reading